Vaccitech (NASDAQ:VACC – Get Rating) had its price objective decreased by HC Wainwright from $20.00 to $15.00 in a research note released on Monday, The Fly reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Vaccitech’s Q1 2023 earnings at ($0.68) EPS, Q2 2023 earnings at ($0.70) […]
Vaccitech plc (NASDAQ:VACC – Get Rating) CEO William Enright sold 15,000 shares of the business’s stock in a transaction on Monday, March 27th. The stock was sold at an average price of $2.42, for a total transaction of $36,300.00. Following the completion of the transaction, the chief executive officer now owns 728,454 shares in the […]
Vaccitech (NASDAQ:VACC – Get Rating) had its target price decreased by Barclays from $23.00 to $7.00 in a report issued on Sunday morning, The Fly reports. Separately, HC Wainwright restated a buy rating and set a $20.00 price objective on shares of Vaccitech in a research report on Tuesday, March 21st. Vaccitech Trading Up 12.1 […]
Vaccitech (NASDAQ:VACC – Get Rating) had its price target lowered by Barclays from $23.00 to $7.00 in a research note published on Sunday morning, The Fly reports. Separately, HC Wainwright restated a buy rating and issued a $20.00 target price on shares of Vaccitech in a report on Tuesday, March 21st. Vaccitech Stock Down 9.7 […]
Vaccitech (NASDAQ:VACC – Get Rating) had its target price decreased by analysts at Barclays from $23.00 to $7.00 in a research note issued on Sunday, The Fly reports. Barclays‘s target price would suggest a potential upside of 183.40% from the company’s previous close. Separately, HC Wainwright reiterated a “buy” rating and set a $20.00 price […]